600 head-up tilt testing was undertaken for 45 minutes, initially without drug provocation. Patients who remained symptom free were given intravenous isoprenaline (isoproterenol) and firther tilting or edrophonium (10 mg bolus) during tilt, in an order determined randomly before the start of the test. If they were symptom free after the first drug, they were given the other drug. A positive test was recorded when syncope or pre-syncope occurred with a rapid fall (> 30%) in blood pressure. The impact on tilt result of the type of symptoms, presence of significant structural heart disease (SHD), presence of a non-cardiovascular cause of sudden diminished consciousness (SDC), and age was then assessed by subgroup analysis. Patients Patients with recurrent syncope rather than single syncopal episodes or single or recurrent pre-syncope were more likely to have a positive tilt test (41% v 17%, P < 0.005) and patients with SHD or SDC (69114 patients) were much less likely than patients without (16% v 42%, P < 0.0001).
The yield of positive tests was similar if patients were below (26%) or above (27%) the mean age (50 years). When multiple factors were combined, the yield ranged from 0% for 21 patients under 50 years with SHD or SDC and without recurrent syncope to 73% in 11 patients over 50 years with recurrent syncope and no SHD or SDC. The additional yield in subgroups over 45 minute baseline tilt (70 (11)%) of isoprenaline (13 (10) study), and orthotopic heart transplantation in three patients. One patient had hypertrophic cardiomyopathy and one had long-QT syndrome. Fourteen patients had SDC, including significant anaemia (haemoglobin concentration < 9 g/dl) in three, severe Parkinson's disease in two, a meningioma in one patient, a seizure disorder in one patient, hyponatraemia (plasma sodium concentration < 120 mEq/l) in one patient, hypothyroidism in two patients, severe obstructive airways disease in three patients, and cocaine abuse in one patient. Sixty two patients had no SHD or SDC.
TILT RESULTS (FIGURE) Role ofpatient characteristics In the whole group 39 patients (27%, 21 female, age 49 (25) years) had positive and 106 (73%, 52 female, age 52 (25) years) negative tilt tests. Twenty seven positive tests (69%) occurred during baseline tilt at 20-5 (10-8) minutes, five (13%) with isoprenaline infusion, and seven (18%) with edrophonium bolus.
Fifty eight patients who had presented with recurrent syncope, rather than single syncopal episodes or single or recurrent pre-syncope, had a much higher yield from tilt testing (41% v 17%, P < 0 005). In the 83 patients with SHD or SDC there was a much lower yield than in the 62 patients without (16% v 42%, P < 0-0001). The yield was similar in the 65 patients below, as compared with the 80 patients above, the mean age (26% v 27%, P = NS).
When multiple variables were combined a much greater discrepancy in the yield of tilttesting became apparent between subgroups. In patients without SHD or SDC those with recurrent syncope (29 patients) had a much higher yield (59%) than those with only single syncopal episodes or only pre-syncope (33 patients, 27% positive, P < 0 03). In patients with SHD or SDC there was no significant increase in yield if patients complained of recurrent syncope (seven of 29 patients, 24%) than if they did not, (six of 54 patients, 11%, P = NS). In patients over the mean age with SHD or SDC, recurrence of syncope rather than single episodes or pre-syncope alone made no difference to yield. Five of 23 patients over 50 years (22%) with SHD or SDC and recurrent syncope had a positive response, as did six of 33 (18%) without recurrent syncope. This yield was similar to that in 14 patients over 50 without structural heart disease and without recurrent syncope (three of 14, 21 %). There was no difference in yield between patients with recurrent syncope and no SHD or SDC under 50 years (nine of 18, 50%) and those over 50 years (eight of 11, 73%, P = NS).
The highest yield of all was seen in patients over 50 years without SHD or SDC presenting with recurrent syncope, with eight of 11 patients (73%) having positive tests. This was significantly higher than in patients over 50 without SHD or SDC but without recurrent syncope (three of 14 (21%), P < 0'01), patients over 50 with recurrent syncope but with SHD or SDC (five of 23 (22%), P < 0 005), and patients over 50 with SHD or SDC but without recurrent syncope, (six of 33 (18%), P < 0-0001) Among younger patients below 50 years, the highest yield was seen in 18 patients with recurrent syncope and no SHD or SDC (nine of 18 (50%)). The Twelve patients had positive tilts during drug provocation after a negative 45 minute baseline tilt: five during isoprenaline infusion and seven with edrophonium injection. Of these, two were isoprenaline positive after negative responses to edrophonium injection and four were edrophonium positive after negative responses to isoprenaline infusion. Among the 20 subgroups of patients identified by clinical characteristics (figure), the additional yield of isoprenaline (13 (10) agnosed. Such patients might benefit from the reassurance of being diagnosed, or from medical treatment. Conversely, investigating patients under 50 years without recurrent syncope but with structural heart disease initially by tilt testing is not justified on the basis of these results. Such an approach may even be hazardous to the patient. A positive test is much more likely statistically to be a false positive. Other tests much more likely to yield true positive results, such as electrophysiological testing, may be neglected, resulting in a misdiagnosis and inappropriate management.
These findings also help to explain the wide range of yields of tilt testing in published reports. As many as 75%1 and as few as 24%9 of adult patients with recurrent syncope have been shown to have symptoms reproduced during head-up tilting. Until now one conclusion that could be drawn was that the results of this test were not reproducible between centres. However, this study suggests that one of the likely reasons is a difference in the type of patients being tested.
Another important cause of confusion over the utility of head-up tilt testing is the large number of different protocols in use. This has been the result of a rapid growth in interest, and no clear standardisation. Variables include the angle of tilt (60-90°' 10), the duration of baseline tilt, (10-60 minutes21I), the use of vascular instrumentation (none,' venous and arterial cannulati6n2 3), the use of drug provocation (none,' isoprenaline,245 glyceryl trinitrate,7 edrophonium8). It has been shown by direct comparison that an angle of tilt less than 600 reduces yield,'2 but not that a greater angle increases it or leaves it unchanged. A number of different tilt angles have been reported, however,' 1013 making comparison difficult. This study suggests that if prolonged baseline 600 tilting is used, the great majority of positive responses will occur without the need for drug provocation. This is likely to be because patients who would have had a positive response during drug administration with a shorter period of baseline tilt do so with protracted baseline tilt, shifting yield from one phase of the study to another. Analysis of the time of tilt-positivity during the baseline period shows a fairly even distribution of positive tests for every 10 minute period up to 40 minutes. The largest yield was between 20 and 29 minutes (10 of 27, 37%), which encompasses the mean value of time to syncope in this study (20-5 (10.8) minutes) and that of another (25 (10) minutes),'2 on the basis of which we chose a baseline tilt period of 45 minutes (mean + 2 standard deviations) . 12 An important question for the busy clinician is whether early drug provocation will maintain or possibly increase the yield of tilting, without loss of specificity, while shortening the test. Most baseline positives can be expected at around the 20th minute of 60°t ilt,'2 however, and the time taken for many complete isoprenaline protocols can be considerable. Titrating heart rate during isoprenaline infusion with the patient returned to the supine position typically takes 10-15 minutes. Even if the patient is immediately syncopal upon returning to 60°, the maximum time saving over 45 minute baseline tilt is only 10 minutes. If the test is not immediately positive, some protocols require a patient to undergo a graded infusion of isoprenaline up to 5 ,ug/min,4 with each graded increase followed by re-tilting to 600, punctuated by a period of further infusion in the supine position. Consequently, up to two hours are required for a negative test.
The specificity of such protocols is also a cause of concern. Some studies have indicated that the false positive response rate of isoprenaline-tilt in control populations may be as high as 40-50%.13 14 In the case of administration of an edrophonium bolus during tilt, this study shows promise, in that the yield of tilting is apparently increased to a similar extent as with isoprenaline, but prolonged titration and resetting of the tilt table are not needed. However, caution is required since there are presently only limited data available on the specificity of edrophonium based on its use in control subjects. In the study by Lurie et al,8 from UCSF, however, only one of 20 control subjects had a positive response with edrophonium challenge. Of concern in this study, are the 50% of patients who had positive tilt table tests with the second drug in the drug provocation sequence. In two cases the test was positive with isoprenaline after administration of edrophonium had produced no effect, and in four cases the test was positive with administration of edrophonium after isoprenaline failed to result in a positive test. There is a high likelihood of a increased number of false positive results after prolonged baseline tilt and the administration of two provocative agents.
Intravascular instrumentation has been shown to increase greatly the number of syncopal responses to orthostatic stress, particularly in young subjects. '5 In patients undergoing tilt table testing prolonged baseline 60°tilt has a very high yield, and a high specificity, albeit with a presently unknown sensitivity, and should become standard practice. If 45 minute baseline tilt is negative, drug provocation may be used, but it should be appreciated that additional yield gained may be at the expense of specificity. Edrophonium may be superior to isoprenaline for use as a provocative agent. However, in this study, in 50% of edrophonium positive cases a bolus administration of the drug during tilt resulted in a positive test when both prolonged baseline tilt and isoprenaline challenge had been negative, raising questions about its specificity. Furthermore, there are few available data to assess the specificity of edrophonium, and it cannot be recommended in place of isoprenaline until its specificity is better understood.
CONCLUSIONS
This study shows that the clinical characteristics of patients with unexplained syncope or pre-syncope are critically important in determining the result of tilt table testing. Prolonged baseline tilt testing has a high yield with an additional much smaller yield from drug provocation. More data are needed to assess whether this additional yield is gained at the expense of specificity.
and serology for syphilis were negative.
Any explanation to account for the pathology requires consideration of the cause of chest pain. This patient may have had an intense vasospastic potential and shut down her arteries over the catheters, thus allowing thrombus to develop. According to this hypothesis spasm would have been the cause of her prior angina. Alternatively she may have had an intense thrombotic potential which became manifest when the endothelium was damaged by catheters in the coronary orifices. This does not, however, explain the previous angina.
Anterior view of the ascending aorta showing thrombi at each coronary ostia.
